Author： Fernandez N. Garca J.L. Garca-Villalon A.L. Monge L. Gomez B. Dieguez G.
Publisher： Elsevier
ISSN： 0014-2999
Source： European Journal of Pharmacology, Vol.342, Iss.2, 1998-01, pp. : 225-233
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Garcia J.L. Fernandez N. Garcia-Villalon A.L. Monge L. Gomez B. Dieguez G.
European Journal of Pharmacology, Vol. 315, Iss. 2, 1996-11 ,pp. :
Access to resources
Recommend
By Martinez M.A. Fernandez N. Climent B. Garcia-Villalon A.-L. Monge L. Sanz E. Dieguez G.
European Journal of Pharmacology, Vol. 473, Iss. 1, 2003-07 ,pp. :
Molecular Pharmacology of V 1a Vasopressin Receptors
General Pharmacology, Vol. 26, Iss. 6, 1995-10 ,pp. :
By Fernandez N. Martnez M.A. Climent B. Garca-Villalon A.L. Monge L. Sanz E. Dieguez G.
European Journal of Pharmacology, Vol. 457, Iss. 2, 2002-12 ,pp. :
Properties of a new radioiodinated antagonist for human vasopressin V 2 and V 1a receptors
By Ala Y. Morin D. Mahe E. Cotte N. Mouillac B. Jard S. Barberis C. Tribollet E. Dreifuss J.-J. Sawyer W.H. Wo N.C. Chan W.Y. Kolodziejczyk A.S. Cheng L.L. Manning M.
European Journal of Pharmacology, Vol. 331, Iss. 2, 1997-07 ,pp. :